We have located links that may give you full text access.
CLINICAL TRIAL
JOURNAL ARTICLE
Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation.
Introduction: Type 2 diabetes mellitus (T2DM) is a well-recognised risk factor for cardiovascular disease and the prevalence of atrial fibrillation (AF) is higher among patients with T2DM. Direct current cardioversion (DCCV) is an important management option in persistent AF. We sought to determine independent risk factors for immediate and short-term outcomes of DCCV for treatment of AF in patients with T2DM.
Methods: Retrospective outcome analysis of DCCV for persistent AF in 102 T2DM patients compared with 102 controls.
Results: DCCV was successful in 68 (66.6%) people with T2DM compared to 86 (84.3%) in the control group ( P = 0.003). After initial successful cardioversion, only 38 (37.2%) T2DM patients remained in sinus rhythm compared to 63 (61.8%) in the control group ( P = 0.007) at a median follow-up of 74.5 days (IQR 69.4-77.4). Multiple logistic regression analysis showed that the presence of T2DM ( P = 0.014), digoxin use ( P = 0.01), statin use ( P = 0.005), left-atrial size ( P = 0.01), and LV ejection fraction ( P = 0.008) were independent risk factors for immediate DCCV failure. T2DM ( P = 0.034) was an independent risk factor for AF relapse. Among patients with T2DM, previous DCCV ( P = 0.033), digoxin use ( P = 0.035), left-atrial size ( P = 0.01), LV ejection fraction ( P = 0.036), and HbA1c ( P = 0.011) predicted immediate failure of DCCV whilst digoxin use ( P = 0.026) was an independent risk factor for relapse of AF.
Conclusion: T2DM, higher HbA1c, digoxin treatment, and structural and functional cardiac abnormalities are independent risk factors for immediate DCCV failure and AF relapse.
Methods: Retrospective outcome analysis of DCCV for persistent AF in 102 T2DM patients compared with 102 controls.
Results: DCCV was successful in 68 (66.6%) people with T2DM compared to 86 (84.3%) in the control group ( P = 0.003). After initial successful cardioversion, only 38 (37.2%) T2DM patients remained in sinus rhythm compared to 63 (61.8%) in the control group ( P = 0.007) at a median follow-up of 74.5 days (IQR 69.4-77.4). Multiple logistic regression analysis showed that the presence of T2DM ( P = 0.014), digoxin use ( P = 0.01), statin use ( P = 0.005), left-atrial size ( P = 0.01), and LV ejection fraction ( P = 0.008) were independent risk factors for immediate DCCV failure. T2DM ( P = 0.034) was an independent risk factor for AF relapse. Among patients with T2DM, previous DCCV ( P = 0.033), digoxin use ( P = 0.035), left-atrial size ( P = 0.01), LV ejection fraction ( P = 0.036), and HbA1c ( P = 0.011) predicted immediate failure of DCCV whilst digoxin use ( P = 0.026) was an independent risk factor for relapse of AF.
Conclusion: T2DM, higher HbA1c, digoxin treatment, and structural and functional cardiac abnormalities are independent risk factors for immediate DCCV failure and AF relapse.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app